Ascending Multiple-Dose Study of BMS-817378 in Subjects With Advanced Cancers

NCT00792558 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: BMS-817378

Sponsor

Bristol-Myers Squibb